Our group is principally involved in chemical design, synthesis, structure, reactivities, mechanisms, and biological properties of small organic and inorganic molecules.
Professor David Fairlie is the group leader for Chemistry and Human Therapeutics research at the IMB. Head, Division of Chemistry & Structural Biology.
